Literature DB >> 29119056

Downregulation of cyclin-dependent kinase 8 by microRNA-148a suppresses proliferation and invasiveness of papillary thyroid carcinomas.

Chun Han1, Weihui Zheng1, Minghua Ge1, Kejing Wang1, Yangfeng Xiang1, Peng Wang1.   

Abstract

MicroRNAs (miRNAs) are important gene regulators that play key roles in tumor genesis. In this study, we investigate the role of miR-148a in the development of papillary thyroid cancer (PTC). Data from the cancer genome atlas (TCGA) indicate that miR-148a is downregulated in PTC tissues; we also find that miR-148a is downregulated in tissue samples from PTC patients and PTC cell lines. Overexpression of miR-148a significantly suppresses PTC cell proliferation, migration and invasiveness in vitro, and inhibits tumor growth in vivo as well. We have identified the cyclin-dependent kinase 8 (CDK8) gene as a direct target of miR-148a using the online software packages TargetScan and miRanda. Overexpression of miR-148a significantly represses CDK8 expression by directly targeting the 3'-untranslated region (3'-UTR) of the CDK8 gene in PTC tissues and cell lines; overexpression of CDK8 reverses the inhibitory effects of miR-148a on PTC cell growth, migration and invasiveness. Taken together, our results indicate that miR-148a functions as a tumor suppressor in PTC by repressing CDK8 expression.

Entities:  

Keywords:  cyclin-dependent kinase 8 (CDK8); metastasis; miR-148a; papillary thyroid carcinoma (PTC); proliferation

Year:  2017        PMID: 29119056      PMCID: PMC5665854     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  23 in total

1.  Platelet-rich plasma increases proliferation of tendon cells by modulating Stat3 and p27 to up-regulate expression of cyclins and cyclin-dependent kinases.

Authors:  T-Y Yu; J-H S Pang; K P-H Wu; L-P Lin; W-C Tseng; W-C Tsai
Journal:  Cell Prolif       Date:  2015-05-25       Impact factor: 6.831

2.  Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis?

Authors:  Miguel Melo; Adriana Gaspar da Rocha; João Vinagre; Manuel Sobrinho-Simões; Paula Soares
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

3.  Papillary thyroid carcinoma metastasizing to anaplastic meningioma: an unusual case of tumor-to-tumor metastasis.

Authors:  Sumit Das; Navjot Chaudhary; Lee-Cyn Ang; Joseph S Megyesi
Journal:  Brain Tumor Pathol       Date:  2017-06-09       Impact factor: 3.298

4.  miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.

Authors:  Christian Philipp Pallasch; Michaela Patz; Yoon Jung Park; Susanne Hagist; Daniela Eggle; Rainer Claus; Svenja Debey-Pascher; Alexandra Schulz; Lukas P Frenzel; Julia Claasen; Nadine Kutsch; Günter Krause; Christine Mayr; Andreas Rosenwald; Christoph Plass; Joachim L Schultze; Michael Hallek; Clemens-Martin Wendtner
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

5.  Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer.

Authors:  Martina S J McDermott; Alexander A Chumanevich; Chang-Uk Lim; Jiaxin Liang; Mengqian Chen; Serena Altilia; David Oliver; James M Rae; Michael Shtutman; Hippokratis Kiaris; Balázs Győrffy; Igor B Roninson; Eugenia V Broude
Journal:  Oncotarget       Date:  2017-02-21

6.  MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.

Authors:  Yu You; Jia-Xin Tan; Hai-Su Dai; Hao-Wei Chen; Xue-Jun Xu; Ai-Gang Yang; Yu-Jun Zhang; Lian-Hua Bai; Ping Bie
Journal:  Oncotarget       Date:  2016-08-30

7.  CDK8: a new breast cancer target.

Authors:  John Crown
Journal:  Oncotarget       Date:  2017-02-28

8.  Depletion of γ-glutamylcyclotransferase inhibits breast cancer cell growth via cellular senescence induction mediated by CDK inhibitor upregulation.

Authors:  Kengo Matsumura; Susumu Nakata; Keiko Taniguchi; Hiromi Ii; Eishi Ashihara; Susumu Kageyama; Akihiro Kawauchi; Tatsuhiro Yoshiki
Journal:  BMC Cancer       Date:  2016-09-22       Impact factor: 4.430

9.  MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.

Authors:  Cilene Rebouças Lima; Murilo Vieira Geraldo; Cesar Seigi Fuziwara; Edna Teruko Kimura; Marinilce Fagundes Santos
Journal:  BMC Cancer       Date:  2016-02-16       Impact factor: 4.430

10.  MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.

Authors:  Wangwang Qiu; Zhili Yang; Youben Fan; Qi Zheng
Journal:  Oncotarget       Date:  2016-06-28
View more
  8 in total

1.  LncRNA UCA1 attenuated the killing effect of cytotoxic CD8 + T cells on anaplastic thyroid carcinoma via miR-148a/PD-L1 pathway.

Authors:  Xiaoming Wang; Yan Zhang; Jian Zheng; Cuixian Yao; Xiubo Lu
Journal:  Cancer Immunol Immunother       Date:  2021-01-24       Impact factor: 6.968

2.  PKM2 functions as a potential oncogene and is a crucial target of miR-148a and miR-326 in thyroid tumorigenesis.

Authors:  Gang Yu; Weili Sun; Yong Shen; Yongquan Hu; Henchao Liu; Weipeng Li; Yong Wang
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

3.  MicroRNA-101 Targets CXCL12-Mediated Akt and Snail Signaling Pathways to Inhibit Cellular Proliferation and Invasion in Papillary Thyroid Carcinoma.

Authors:  Fang Chen; Dongqiang Yang; Yuhua Ru; Shan Cao; Aishe Gao
Journal:  Oncol Res       Date:  2019-03-04       Impact factor: 5.574

4.  MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8.

Authors:  Mohamed A Elkady; Ahmed S Doghish; Ahmed Elshafei; Mostafa M Elshafey
Journal:  Saudi J Biol Sci       Date:  2021-02-14       Impact factor: 4.219

5.  lncRNA HOTAIRM1 regulates cell proliferation and the metastasis of thyroid cancer by targeting Wnt10b.

Authors:  Chenyao Li; Xinxin Chen; Tao Liu; Guang Chen
Journal:  Oncol Rep       Date:  2020-12-31       Impact factor: 3.906

Review 6.  MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Authors:  Maria Papaioannou; Angeliki G Chorti; Anthoula Chatzikyriakidou; Kleanthis Giannoulis; Sohail Bakkar; Theodosios S Papavramidis
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

7.  miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer.

Authors:  Min Bao; Yingjian Song; Jingjing Xia; Pengling Li; Qing Liu; Zongren Wan
Journal:  Onco Targets Ther       Date:  2018-03-26       Impact factor: 4.147

8.  Long Non-Coding RNA HOXA11-AS Promotes Non-Small Cell Lung Cancer Tumorigenesis Through microRNA-148a-3p/DNMT1 Regulatory Axis.

Authors:  Yue Bai; Lili Lang; Wentao Zhao; Rong Niu
Journal:  Onco Targets Ther       Date:  2019-12-17       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.